Perfuse Therapeutics
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $9M
Investors
- 4
About Perfuse Therapeutics
Perfuse Therapeutics, Inc.Perfuse Therapeutics is dedicated to creating therapies that improve blood flow to the retina to combat critical ocular diseases. Founded by Sevgi Gurkan, the company is headquartered in San Francisco, US.21 mn.Perfuse Therapeutics specializes in developing innovative therapies aimed at enhancing blood flow to the retina, targeting critical ocular diseases such as glaucoma and diabetic retinopathy. Their core offering is a first-in-class endothelin antagonist designed to mitigate the effects of ischemia in ocular tissues, addressing the underlying pathologies associated with these conditions.The revenue model for Perfuse Therapeutics is centered around the commercialization of its flagship endothelin antagonist. This model is likely structured through partnerships with healthcare providers and distributors within the ophthalmology sector, facilitated via B2B relationships with hospitals, clinics, and specialty pharmacies. The company also aims to expand its market presence, focusing on regions with a high incidence of glaucoma and diabetic retinopathy. These strategic initiatives are expected to enhance the company's capacity to deliver innovative therapeutic solutions to its target market.
Who invested in Perfuse Therapeutics
4 investors across 1 round
See all investors in Perfuse Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 15, 2020
Amount
$9M
Investors
Questions about Perfuse Therapeutics
Who invested in Perfuse Therapeutics?
Perfuse Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Perfuse Therapeutics raised?
Perfuse Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Perfuse Therapeutics last raise money?
Perfuse Therapeutics's most recent round on record is a Series A, in Jul 2020.
What does Perfuse Therapeutics do?
Perfuse Therapeutics is a biotechnology company.
Where is Perfuse Therapeutics headquartered?
Perfuse Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Perfuse Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Perfuse Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Perfuse Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.